Psychopharmacology of Anorexia Nervosa, Bulimia Nervosa, and Binge Eating

B. Timothy Walsh and Michael J. Devlin
Department of Clinical Psychiatry
Columbia University College of Physicians and Surgeons
New York, New York 10032


Eating Disorders Unit
New York State Psychiatric Institute
New York, New York 10032.


1. Agras WS, Dorian B, Kirkley BG, Arnow B, Bachman J. Imipramine in the treatment of bulimia: a double-blind controlled study. Int J Eat Disord 1987;6:2938.

2. Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, Bruce B, Perl M, Koran LM. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry 1992;49:8287.

3. Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ. Effect of a tricyclic antidepressant and opiate antagonist on binge-eating in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr 1991;53:865871.

4. Barlow J, Blouin J, Blouin A, Perez E. Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychiatry 1988;330:129133.

5. Barry VC, Klawans HL. On the role of dopamine in the pathophysiology of anorexia nervosa. J Neural Transm 1976;38:107122.

6. Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak PJ, Schildkraut JJ. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol 1985;5:1016.

7. Blouin AG, Blouin JH, Perez EL, Bushnik T, Zuro C, Mulder E. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988;8:261269.

8. Casper RC, Schlemmer RF, Javaid JI. A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res 1987;20:249260.

9. Channon S, DeSilva WP. Psychological correlates of weight gain in patients with anorexia nervosa. J Psychiatr Res 1985;19:267271.

10. Condon JT. Long-term neuroleptic therapy in chronic anorexia nervosa complicated by tardive dyskinesia. A case report. Acta Psychiatr Scand 1986;73:203206.

11. Crisp AH. A treatment regime for anorexia nervosa. Br J Psychiatry 1966;112:505512.

12. Crisp AH, Lacey JH, Crutchfield M. Clomipramine and `drive' in people with anorexia nervosa: an in-patient study. Br J Psychiatry 1987;150:355358.

13. Dally P, Sargant W. A new treatment of anorexia nervosa. Br Med J 1960;1:17701773.

14. Dally P, Sargant W. Treatment and outcome of anorexia nervosa. Br Med J 1966;2:793795.

15. de Zwaan M, Nutzinger DO, Schoenbeck G. Binge eating in overweight women. Compr Psychiatry 1992;33:256261.

16. Eckert ED, Goldberg SC, Halmi KA, Casper RC, Davis JM. Depression in anorexia nervosa. Psychol Med 1981;11:18.

17. Fahy TA, Eisler I, Russell GFM. A placebo-controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry 1993;162:597603.

18. Faltus F, Janeckova E. Levoprotiline-function regulator of food and satiety centres? Act Nerv Super (Praha) 1989;31:282283.

19. Fava M, Herzog DB, Hamburg P, Riess H, Anfang S, Rosenbaum JF. Long-term use of fluoxetine in bulimia nervosa: a retrospective study. Ann Clin Psychiatry 1990;2:5356.

20. Ferguson JM. Treatment of an anorexia nervosa patient with fluoxetine [Letter]. Am J Psychiatry 1987;144:12391239.

21. Fichter MM, Leibl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR. Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991;24:17.

22. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebocontrolled, double-blind trial. Arch Gen Psychiatry 1992;49:139147.

23. Franklin JC, Schiele BC, Brozek J, Keys A. Observations on human behavior in experimental semistarvation and rehabilitation. J Clin Psychol 1948;4:2845.

24. Freeman CPL, Davies F, Morris J, Cheshire K, Hampson M. A double-blind controlled trial of fluoxetine versus placebo for bulimia nervosa. Unpublished report, 1989.

25. Goldberg SC, Halmi KA, Eckert ED, Casper RC, Davis JM. Cyproheptadine in anorexia nervosa. Br J Psychiatry 1979;134:6770.

26. Gross HA, Ebert MH, Faden VB, Goldberg SC, Nee Le, Kaye WH. A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1981;1:376381.

27. Gwirtsman HE, Guze BH, Yager J, Gainsley B. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 1990;51:378382.

28. Halmi KA, Eckert ED, LaDu TJ, Cohen J. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986;43:177181.

29. Horne RL, Ferguson JM, Pope HG, Hudson JI, Lineberry CG, Ascher J, Cato A. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988;49:262266.

30. Hsu LKG. Eating disorders. New York: The Guilford Press, 1990.

31. Hsu LKG, Clement L, Santhouse R, Ju ESY. Treatment of bulimia nervosa with lithium carbonate. A controlled study. J Nerv Ment Dis 1991;179:351355.

32. Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM. Treating bulimia with desipramine: a double-blind, placebo-controlled study. Arch Gen Psychiatry 1986;43:182186.

33. Kaye WH, Weltzin TE, Hsu LKG, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991;52:464471.

34. Kennedy SH, Goldbloom DS, Ralevski E, Davis C, D'Souza J, Lofchy J. Is there a role for selective MAO-inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. J Clin Psychopharmacol 1993;13:415422.

35. Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE. A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 1988;8:391396.

36. Lacey JH, Crisp AH. Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 1980;56(Suppl 1):7985.

37. Leitenberg H, Rosen JC, Wolf J, Vara LS, Detzer MJ, Srebnik D. Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. Behav Res Ther 1994;32:3745.

38. Marcus MD, Wing RR, Ewing L, Kern E, Gooding W, McDermott M. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge eaters and non-binge eaters. Am J Psychiatry 1990;147:876881.

39. McCann UD, Agras WS. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry 1990;147:15091513.

40. Mitchell JE. Psychopharmacology of anorexia nervosa. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987;12731276.

41. Mitchell JE, Christenson G, Jennings J, Huber M, Thomas B, Pomeroy C, Morley J. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. J Clin Psychopharmacol 1989;9:9497.

42. Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984;4:186193.

43. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990;47:149157.

44. Pope HG, Hudson JI, Jonas JM, Yurgelun-Todd D. Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 1985;5:320327.

45. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 1983;140:554558.

46. Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989;9:254259.

47. Potvin JH, Rampey AH, Roberts AH, Wheadon VL, Wilson MG. Fluoxetine vs. placebo in long-term treatment of bulimia nervosa: parallel/double-blind. Unpublished report, 1990.

48. Pyle RL, Mitchell JE, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment. Am J Psychiatry 1990;147:7:871875.

49. Russell GFM, Checkley SA, Feldman J, Eisler I. A controlled trial of d-fenfluramine in bulimia nervosa. Clin Neuropharmacol 1988;11(Suppl 1):S146S159.

50. Sabine EJ, Yonace A, Farrington AJ, Barratt KH, Wakeling A. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol 1983;15:195S202S.

51. Slaiman S. Restricted diets restrict antidepressant efficacy. Practitioner 1989;233:974975.

52. Spitzer RL, Devlin MJ, Walsh BT, Hasin D, Wing RR, Marcus MD, Stunkard A, Wadden TA, Yanovski S, Agras WS, Mitchell J, Nonas C. Binge eating disorder: a multisite field trial for the diagnostic criteria. Int J Eat Disord 1992;11:191203.

53. Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, Devlin M, Mitchell J, Hasin D, Horne RL. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137153.

54. Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa: a double-blind placebo-controlled study with sulpiride. Br J Psychiatry 1984;144:288292.

55. Vandereycken W, Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. Acta Psychiatr Scand 1982;66:445450.

56. Vigersky RA, Loriaux DL. The effect of cyproheptadine in anorexia nervosa: a double-blind trial. In: Vigersky RA, ed. Anorexia nervosa. New York: Raven Press, 1977;349356.

57. Walsh BT. Fluoxetine in the treatment of bulimia nervosa. J Psychosom Res 1991;35(Suppl 1):3340.

58. Walsh BT, Gladis M, Roose SP, Stewart JW, Stetner F, Glassman AH. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 1988;45:471475.

59. Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 1991;148:12061212.

Back to Chapter

published 2000